Resmed Aktie
Marktkapitalisierung
31,57 Mrd. $
31,57 Mrd. $
Streubesitz
33,73%
KGV
27,66
Dividende
1,92 $
Dividendenrendite
1,05%
neu:
Nachhaltigkeits-Score
Index-Zuordnung
Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
Resmed Strengthens Innovation Leadership with Dual Red Dot Design Awards and 10,000 Patents and Designs
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio